STRIVE Post-Market Registry Study
NCT04302272
This study is recruiting at 15 US sites in 12 states, according to its ClinicalTrials.gov record last updated .
Summary
This is a single-arm, prospective, multi-center, Registry study to evaluate the long-term safety and effectiveness of the Spiration Valve System (SVS) for the treatment of severe emphysema in a post-market setting.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Emphysema
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Olympus Corporation of the Americas
- Last updated on ClinicalTrials.gov
- August 3, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- Dignity Health St. Joseph's Hospital and Medical Center · Phoenix, AZ
California · 1
- El Camino, Taft Center for Clinical Research · Mountain View, CA
Florida · 1
- University of Miami · Coral Gables, FL
Illinois · 2
- Northwestern University, Division of Pulmonary and Critical Care Medicine · Chicago, IL
- University of Chicago · Chicago, IL
Louisiana · 1
- LSU Health Shreveport · Shreveport, LA
Maryland · 1
- University of Maryland · Baltimore, MD
Massachusetts · 1
- Beth Israel Decaconess · Boston, MA
Mississippi · 1
- Memorial Hospital at Gulfport · Gulfport, MS
North Carolina · 1
- Duke University Medical Center · Durham, NC
Pennsylvania · 2
- Penn State Milton S. Hershey Medical Center · Hershey, PA
- Temple University · Philadelphia, PA
South Carolina · 1
- AnMed Health · Anderson, SC
Texas · 2
- Baylor Scott & White Research Institute · Dallas, TX
- University of Texas Southwestern · Dallas, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.